NCT02279602 2018-04-17
Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study
Mateon Therapeutics
Phase 2 Completed
Clinical Trials
8 trialsNCT02132468 2017-12-05
GI-NETorPNET
Mateon Therapeutics
Phase 2 Completed
NCT00653939 2015-02-09
FALCON
Mateon Therapeutics
Phase 2 Completed
NCT00003768 2014-01-07
Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors
Case Comprehensive Cancer Center
Phase 1 Completed
NCT00003698 2013-12-19
Chemotherapy in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00113438 2011-11-01
Safety and Effectiveness of Combretastatin A-4 Phosphate Combined With Chemotherapy in Advanced Solid Tumors
Mateon Therapeutics
Phase 2 Completed
NCT00395434 2011-10-31
Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid Tumors
Mateon Therapeutics
Phase 1 Completed
NCT00060242 2010-06-11
Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer
Case Comprehensive Cancer Center
Phase 2 Completed